Antivirals and other Antimicrobials Flashcards

1
Q

Class: zidovudine

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Side effect: zidovudine

A

CNS disturbances: confusion, seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Class: lamivudine

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Side effect: lamivudine

A

None. Has activity against hepatitis B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Class: emtricitabine

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Side effect: emtricitabine

A

None. Has activity against hepatitis B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Class: didanosine

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Side effect: didanosine

A

Pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Class: zalcitabine

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side effect: zalcitabine

A

Pancreatitis (uncommon), oral ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Class: stavudine

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side effect: stavudine

A

Increased hepatic transaminases, lipoatrophy, hyperlipidemia, lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Class: abacavir

A

Nucleoside RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effect: abacavir

A

Hypersensitivity reactions in HLA-B5701 (requires screening)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class: tenofovir

A

NucleoTide RTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effect: tenofovir

A

Renal impairment with hypophosphotemia. Also has activity against hepatitis B.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nonspecific side effects of NRTI class

A

Peripheral neuropathy, lactic acidosis, fat redistribution (lipodystrophy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Class: nevirapine

A

NNRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Side effect: nevirapine

A

Rash (SJS), elevated LFTs/liver failure

CYP450 inducer–induces it’s own metabolism!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Class: delavirdine

A

NNRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Side effect: delavirdine

A

Rash, elevated LFTs

CYP450 INHIBITOR–increases levels of drugs metabolized by CYP450. Inhibits it’s own metabolism!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Class: efavirenz

A

NNRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Side effect: efavirenz

A
CNS disturbances (abnormal dreams, impaired concentration, somnolence)
CYP450 inducer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Class: etravirine

A

NNRTI–effective in persons with resistance to other NNRTIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Side effect: etravirine
Rash (mild) | CYP450 inducer
26
Class: rilpivirine
NNRTI--effective in persons with resistance to other NNRTIs
27
Side effect: rilpivirine
Depression, insomnia, headache, rash | CYP450 inducer
28
Problem with resistance to NNRTI's?
Resistance against one drug of this class confers resistance to the majority of them. Etravirine and rilpivirine remain effective in strains with prior NNRTI resistance.
29
General side effects of protease inhibitors?
Dyslipidemia, insulin resistance, lipodystrophy
30
Class: saquinavir
Protease inhibitor
31
Side effect: saquinavir
Poorly absorbed --> GI effects (diarrhea, nausea, dyspepsia, vomiting) Reformulated as fortovase which has enhanced bioavailability
32
Class: indinavir
Protease inhibitor
33
Side effect: indinavir
Kidney stones, GI upset (but absorbed well in fasting state)
34
Class: ritonavir
Protease inhibitor
35
Side effect: ritonavir
GI side effects | Potent CYP450 inhibitor (used to "boost" levels of other drugs which allows less frequent dosing)
36
Class: nelfinavir
Protease inhibitor
37
Side effect: nelfinavir
Diarrhea
38
Class: amprenavir/fosamprenavir
Protease inhibitor
39
Side effect: amprenavir/fosamprenavir
GI upset, rash, paresthesias
40
Class: lopinavir
Protase inhibitor. Coformulated with ritonavir as combivir.
41
Side effect: lopinavir/combivir
Mild GI. Well tolerated. | Used during pregnancy.
42
Class: atazanavir
Protease inhibitor
43
Side effect: atazanavir
Indirect bilirubinemia without jaundice. Less impact on lipids. Cannot be taken with PPIs.
44
Class: tipranavir
Protease inhibitor
45
Side effect: tipranavir
GI upset. Coadministered with ritonavir for boosting.
46
Class: darunavir
Protease inhibitor--effective in patients with resistance to other PI's
47
Side effect: darunavir
GI upset. Once daily dosing.
48
Class: enfuvirtide
Fusion inhibitor (binds p41 of envelope)
49
Side effect: enfuvirtide
Injection site reactions, neutropenia | "Salvage regimen"
50
Class: maraviroc
CCR5 inhibitor
51
Side effect: maraviroc
Well tolerated
52
Class: raltegravir
Integrase inhibitor
53
Side effect: raltegravir
Diarrhea, nausea, fatigue
54
Class: elvitegravir
Integrase inhibitor
55
Side effect: elvitegravir
Diarrhea, nausea, proteinuria | Administered in combination with emtricitabine, tenofovir, and cobicistat (CYP450 inhibitor), called Stribild
56
MOA: amantadine, rimantadine
Inhibits viral genome uncoating of influenza A only
57
Class: oseltamivir, zanamivir, peramivir
Neuraminidase inhibitors
58
Clinical use of ribavirin?
RSV in infants, Lassa fever (arenaviridae), hantavirus pulmonary syndrome, HCV (in combination with interferon)
59
Clinical use of interferon?
Treatment of chronic hepatitis B and hepatitis C in combination with ribavirin
60
MOA: boceprevir/telaprevir
Hepatitis C protease NS3-4A inhibitors. | Used in combination with interferon and ribavirin
61
Class: acyclovir/famciclovir/valacyclovir
Guanosine analogue, requires phosphorylation by HERPES thymidine kinase
62
Class: ganciclovir
Guanosine analogue, requires phosphorylation by HUMAN thymidine kinase
63
Class: cidofovir
Cytosine analogue, requires phosphorylation by HUMAN cellular kinases
64
Class: foscarnet
Pyrophosphate analogue which inhibit viral DNA polymerase/reverse transcriptase